Our innovative and patent-protected nano-platform technology could be used for targeted delivery of therapeutic and diagnostic agents. Our platform technology is based on "safe-by-design" and "simple-by-design" concepts that actively deliver therapeutic molecules to the target cells and exert pharmacological activity. This technology is being utilised in our research programs.
Drug delivery to the brain: self-assembled phage mimetics for crossing the blood-brain-barrier
We show that hierarchical forms of a phage display peptide efficiently target the brain and ferry nucleic acid medicines to neurons and microglia